1. Home
  2. GSUN vs LNAI Comparison

GSUN vs LNAI Comparison

Compare GSUN & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

HOLD

Current Price

$1.56

Market Cap

24.0M

Sector

Real Estate

ML Signal

HOLD

Logo Lunai Bioworks Inc. Common Stock

LNAI

Lunai Bioworks Inc. Common Stock

N/A

Current Price

$1.26

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSUN
LNAI
Founded
1997
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
23.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
GSUN
LNAI
Price
$1.56
$1.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
212.4K
3.1M
Earning Date
02-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,314,724.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
526.22
N/A
52 Week Low
$1.25
$0.81
52 Week High
$5.25
$21.00

Technical Indicators

Market Signals
Indicator
GSUN
LNAI
Relative Strength Index (RSI) 43.65 N/A
Support Level $1.29 N/A
Resistance Level $1.58 N/A
Average True Range (ATR) 0.17 0.00
MACD 0.03 0.00
Stochastic Oscillator 72.09 0.00

Price Performance

Historical Comparison
GSUN
LNAI

About GSUN Golden Sun Education Group Limited

Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.

About LNAI Lunai Bioworks Inc. Common Stock

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: